Market Research Logo

RaQualia Pharma Inc. - Product Pipeline Review - 2016

RaQualia Pharma Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘RaQualia Pharma Inc. - Product Pipeline Review - 2016’, provides an overview of the RaQualia Pharma Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by RaQualia Pharma Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of RaQualia Pharma Inc.
  • The report provides overview of RaQualia Pharma Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses RaQualia Pharma Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features RaQualia Pharma Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate RaQualia Pharma Inc.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for RaQualia Pharma Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding RaQualia Pharma Inc.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


RaQualia Pharma Inc. Snapshot
RaQualia Pharma Inc. Overview
Key Information
Key Facts
RaQualia Pharma Inc. - Research and Development Overview
Key Therapeutic Areas
RaQualia Pharma Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
RaQualia Pharma Inc. - Pipeline Products Glance
RaQualia Pharma Inc. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
RaQualia Pharma Inc. - Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
RaQualia Pharma Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
RaQualia Pharma Inc. - Drug Profiles
tegoprazan
Product Description
Mechanism of Action
R&D Progress
RQ-00000010
Product Description
Mechanism of Action
R&D Progress
RQ-00310941
Product Description
Mechanism of Action
R&D Progress
RQ-00000774
Product Description
Mechanism of Action
R&D Progress
RQ-00201894
Product Description
Mechanism of Action
R&D Progress
RQ-00202730
Product Description
Mechanism of Action
R&D Progress
RQ-00203066
Product Description
Mechanism of Action
R&D Progress
RQ-00203078
Product Description
Mechanism of Action
R&D Progress
RQ-00433412
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Block Cav3.2 for Neuropathic Pain
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Block Nav1.7 Sodium Channel for Pain
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Block Nav1.8 Sodium Channel for Pain
Product Description
Mechanism of Action
R&D Progress
RQ-00434739
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Pain
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Undisclosed Indication
Product Description
Mechanism of Action
R&D Progress
RaQualia Pharma Inc. - Pipeline Analysis
RaQualia Pharma Inc. - Pipeline Products by Target
RaQualia Pharma Inc. - Pipeline Products by Route of Administration
RaQualia Pharma Inc. - Pipeline Products by Molecule Type
RaQualia Pharma Inc. - Pipeline Products by Mechanism of Action
RaQualia Pharma Inc. - Recent Pipeline Updates
RaQualia Pharma Inc. - Dormant Projects
RaQualia Pharma Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
RaQualia Pharma Inc., Key Information
RaQualia Pharma Inc., Key Facts
RaQualia Pharma Inc. - Pipeline by Indication, 2016
RaQualia Pharma Inc. - Pipeline by Stage of Development, 2016
RaQualia Pharma Inc. - Monotherapy Products in Pipeline, 2016
RaQualia Pharma Inc. - Phase III, 2016
RaQualia Pharma Inc. - Phase I, 2016
RaQualia Pharma Inc. - Preclinical, 2016
RaQualia Pharma Inc. - Discovery, 2016
RaQualia Pharma Inc. - Pipeline by Target, 2016
RaQualia Pharma Inc. - Pipeline by Route of Administration, 2016
RaQualia Pharma Inc. - Pipeline by Molecule Type, 2016
RaQualia Pharma Inc. - Pipeline Products by Mechanism of Action, 2016
RaQualia Pharma Inc. - Recent Pipeline Updates, 2016
RaQualia Pharma Inc. - Dormant Developmental Projects,2016
RaQualia Pharma Inc., Other Locations
RaQualia Pharma Inc., Subsidiaries
"
List of Figures
RaQualia Pharma Inc. - Pipeline by Top 10 Indication, 2016
RaQualia Pharma Inc. - Pipeline by Stage of Development, 2016
RaQualia Pharma Inc. - Monotherapy Products in Pipeline, 2016
RaQualia Pharma Inc. - Pipeline by Top 10 Target, 2016
RaQualia Pharma Inc. - Pipeline by Route of Administration, 2016
RaQualia Pharma Inc. - Pipeline by Molecule Type, 2016
RaQualia Pharma Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report